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Abstract
© 2017, Springer Science+Business Media New York.The objective of the study was to assess
potential  anti-inflammatory  or  pro-inflammatory  effects  of  haloperidol,  a  classic  typical
neuroleptic, a butyrophenone derivative. It has been hypothesized that the anti-inflammatory
mechanisms of some psychotropic drugs might become a rationale for their use for potential
prevention of neurodegenirative diseases, including Alzheimer’s, which are known to include
chronic inflammation as disease progression component. We looked at the effects of haloperidol
on the acute carrageenan-induced inflammation of rat paws and showed that haloperidol with
prolonged use (for 7 days prior to edema modeling) considerably increased the inflammatory
response at 48 h. A single dose of haloperidol also stimulated the progression of inflammation
but at earlier time points—at 3 and 4 h after carrageenan injection.
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